Coronary Atherosclerosis T1-Weighted Characterization (CATCH)

Status: Recruiting
Location: See location...
Intervention Type: Device, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study proposes to develop an MRI technique named Coronary Atherosclerosis T1-weighed Characterization (CATCH) that will improve the quality and reliability of coronary atherosclerosis evaluation, as well as simplify the scanning process and significantly shorten imaging time compared with conventional imaging methods.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Healthy Volunteers: male or female ≥ 18 years of age with a BMI\<30, with no history of cardiovascular disease

• Patients: Medically stable, male or female ≥ 18 years of age who is have not suspected of having or has been diagnosed with coronary artery disease and undergone stenting or bypass surgery

Locations
United States
California
Cedars-Sinai Medical Center
RECRUITING
Los Angeles
Contact Information
Primary
Rosalia (Sally) A De Leon
Rosalia.DeLeon@cshs.org
310 423-7758
Backup
Debiao Li, PhD
debiao.li@cshs.org
310 423-7743
Time Frame
Start Date: 2018-07-30
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 150
Treatments
Other: Healthy Volunteers
Approximately 110 healthy male/female adult normals or controls will receive non-contrast or contrast-enhanced Cardiac MRI. Imaging may include administration of contrast and a beta blocker, based upon the focus of the study at the time of the scan, as well as the safety profile of the participant.
Other: Coronary Artery Disease (CAD) Patients
40 male/female adult outpatients who are suspected of having or have been diagnosed with coronary artery disease (CAD) will receive non-contrast or contrast-enhanced Cardiac MRI. Imaging may include administration of contrast and a beta blocker, based upon the focus of the study at the time of the scan, as well as the safety profile of the participant.
Related Therapeutic Areas
Sponsors
Leads: Cedars-Sinai Medical Center

This content was sourced from clinicaltrials.gov